Showing results (1-10 of 277) with videos related to
Sort By:
Pageof 28
Acta Bio-Medica : Atenei Parmensis|April 26, 2012
Coxibs: a significant therapeutic opportunityDavide Gatti, Silvano AdamiGiornale Italiano Di Cardiologia (2006)|February 26, 2011
[Vitamin D deficiency, left ventricular dysfunction and heart failure]Giovanni Cioffi, Davide Gatti, Silvano AdamiCalcified Tissue International|June 11, 2013
Involvement of WNT/β-catenin signaling in the treatment of osteoporosisMaurizio Rossini, Davide Gatti, Silvano AdamiJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Epidemiology of primary hyperparathyroidism in EuropeSilvano Adami, Claudio Marcocci, Davide GattiClinical Therapeutics|August 22, 2009
Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated reviewMaurizio Rossini, Ombretta Viapiana, Davide Gatti, et al.Expert Opinion on Pharmacotherapy|September 12, 2015
The use of bisphosphonates in women: when to use and when to stopDavide Gatti, Silvano Adami, Ombretta Viapiana, et al.European Journal of Endocrinology|February 25, 2006
Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient childrenGiorgio Radetti, Gianluca D'Addato, Davide Gatti, et al.Expert Opinion on Pharmacotherapy|May 9, 2013
Osteoporosis treatment: why ibandronic acid?Maurizio Rossini, Giovanni Orsolini, Silvano Adami, et al.Bone Research|August 15, 2015
Osteoporosis Treatment: When to Discontinue and When to Re-startSilvano Adami, Luca Idolazzi, Elena Fracassi, et al.Expert Opinion on Drug Safety|December 25, 2015
Safety issues and adverse reactions with osteoporosis managementMaurizio Rossini, Giovanni Adami, Silvano Adami, et al.Pageof 28